World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
18112
World Ranking
2502
National Ranking
1202

Hideki Hasegawa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hideki Hasegawa sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 317 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hideki Hasegawa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hideki Hasegawa sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hideki Hasegawa is affiliated with the National Institutes of Health in the United States. Their research primarily centers on Medicine, with a strong concentration in Infectious Diseases, Epidemiology, and Immunology. The scientist's work also spans areas such as Animal Science and Zoology as well as Molecular Biology.

The scientist has contributed extensively to topics including:

  • SARS-CoV-2 and COVID-19 Research
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology

Some of Hideki Hasegawa's recent publications include:

  • "Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants," 2022, New England Journal of Medicine
  • "Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2," 2022, Nature
  • "Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017," 2020, Emerging infectious diseases
  • "Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic," 2021, Influenza and Other Respiratory Viruses
  • "Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections," 2020, Journal of Clinical Investigation

Frequent collaborators in their research include Tadaki Suzuki, Shinji Watanabe, Akira Ainai, Seiichiro Fujisaki, and Noriko Kishida. These co-authors have worked with Hasegawa on numerous projects, contributing to a substantial collective output in the field.

Hideki Hasegawa has published extensively in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Viruses
  • Pathology International
  • Influenza and Other Respiratory Viruses

Best Publications

  • The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan

    Toru Takahashi;Ken Maeda;Tadaki Suzuki;Aki Ishido

  • TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection

    Naoko Iwata-Yoshikawa;Tadashi Okamura;Yukiko Shimizu;Hideki Hasegawa

  • Gold Nanoparticles as a Vaccine Platform: Influence of Size and Shape on Immunological Responses in Vitro and in Vivo

    Kenichi Niikura;Tatsuya Matsunaga;Tadaki Suzuki;Shintaro Kobayashi

  • Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

    Unknown

  • Characterization of H7N9 influenza A viruses isolated from humans

    Tokiko Watanabe;Maki Kiso;Satoshi Fukuyama;Noriko Nakajima

  • Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

    Unknown

  • Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection

    Takeshi Ichinohe;Izumi Watanabe;Izumi Watanabe;Satoshi Ito;Satoshi Ito;Hideki Fujii

  • Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I

    Hideki Hasegawa;Hirofumi Sawa;Martha J Lewis;Martha J Lewis;Yasuko Orba

  • Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines

    Yasuko Asahi;Tomoki Yoshikawa;Izumi Watanabe;Takuya Iwasaki

  • Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.

    Tadayoshi Ikebe;Manabu Ato;Takayuki Matsumura;Hideki Hasegawa

  • The Host Protease TMPRSS2 Plays a Major Role in In Vivo Replication of Emerging H7N9 and Seasonal Influenza Viruses

    Kouji Sakai;Yasushi Ami;Maino Tahara;Toru Kubota

  • A Sialylated Voltage-Dependent Ca2+ Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells

    Yoichiro Fujioka;Shinya Nishide;Toyoyuki Ose;Tadaki Suzuki

  • Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs

    Hanako Sekimukai;Hanako Sekimukai;Naoko Iwata‐Yoshikawa;Shuetsu Fukushi;Hideki Tani

  • Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

    Takeshi Ichinohe;Shin-Ichi Tamura;Akira Kawaguchi;Akira Kawaguchi;Akira Kawaguchi;Ai Ninomiya

  • Severe Fever with Thrombocytopenia Syndrome, Japan, 2013-2017.

    Yusuke Kobayashi;Hirofumi Kato;Takuya Yamagishi;Tomoe Shimada

  • Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus

    Hideki Tani;Aiko Fukuma;Shuetsu Fukushi;Satoshi Taniguchi

  • Effects of Toll-like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-inactivated Severe Acute Respiratory Syndrome-related Coronavirus Vaccine

    Naoko Iwata-Yoshikawa;Akihiko Uda;Tadaki Suzuki;Yasuko Tsunetsugu-Yokota

  • Lethal Canine Distemper Virus Outbreak in Cynomolgus Monkeys in Japan in 2008

    Kouji Sakai;Noriyo Nagata;Yasushi Ami;Fumio Seki

  • Mucosal IgA responses in influenza virus infections; thoughts for vaccine design.

    Elly van Riet;Akira Ainai;Tadaki Suzuki;Hideki Hasegawa

  • LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox

    Masayuki Saijo;Yasushi Ami;Yuriko Suzaki;Noriyo Nagata

  • Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.

    M. Zahidunnabi Dewan;Kazuo Terashima;Midori Taruishi;Hideki Hasegawa

  • Characterization of Quasispecies of Pandemic 2009 Influenza A Virus (A/H1N1/2009) by De Novo Sequencing Using a Next-Generation DNA Sequencer

    Makoto Kuroda;Harutaka Katano;Noriko Nakajima;Minoru Tobiume

  • Roles of anti-hemagglutinin IgA and IgG antibodies in different sites of the respiratory tract of vaccinated mice in preventing lethal influenza pneumonia

    Reiko Ito;Yasuko Asahi Ozaki;Tomoki Yoshikawa;Hideki Hasegawa

Frequent Co-Authors

Tetsutaro Sata
Tetsutaro Sata National Institute of Infectious Diseases
Tadaki Suzuki
Tadaki Suzuki National Institutes of Health
Takeshi Kurata
Takeshi Kurata Juntendo University
Harutaka Katano
Harutaka Katano National Institutes of Health
Noriyo Nagata
Noriyo Nagata National Institutes of Health
Hirofumi Sawa
Hirofumi Sawa Hokkaido University
William W. Hall
William W. Hall University College Dublin
Yoshihiro Kawaoka
Yoshihiro Kawaoka University of Tokyo
Masayuki Saijo
Masayuki Saijo National Institute of Infectious Diseases, Tokyo
Shigeru Morikawa
Shigeru Morikawa National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees online can open diverse career opportunities. Many students begin with foundational programs like lpn schools easy to get into, which provide essential practical nursing skills. These programs serve as a stepping stone towards advanced roles in patient care and research.

Advancing further, nursing professionals often pursue specialized degrees such as family nurse practitioner (FNP) programs. The easiest fnp program options allow nurses to expand their clinical expertise and take on more responsibility in healthcare settings linked to immunology and patient immune system management.

For those focused on mental health, particularly in immunology-related psychiatric conditions, the top online pmhnp programs offer strong clinical placements, ensuring hands-on experience in psychiatric-mental health nursing. This practical training is crucial for managing complex immune-related psychiatric disorders.

Budget-conscious learners can also explore affordable pmhnp programs, which provide quality education without breaking the bank. These accessible pathways help expand the immunology workforce by training competent psychiatric nurse practitioners.

Best Scientists Citing Hideki Hasegawa

Trending Scientists

Recently Published Articles